These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19903166)
21. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit. Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835 [TBL] [Abstract][Full Text] [Related]
22. Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity. Tichenor MS; MacMillan KS; Trzupek JD; Rayl TJ; Hwang I; Boger DL J Am Chem Soc; 2007 Sep; 129(35):10858-69. PubMed ID: 17691783 [TBL] [Abstract][Full Text] [Related]
23. Solution structure of the covalent duocarmycin A-DNA duplex complex. Lin CH; Patel DJ J Mol Biol; 1995 Apr; 248(1):162-79. PubMed ID: 7731041 [TBL] [Abstract][Full Text] [Related]
24. Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies. Tietze LF; Krewer B Anticancer Agents Med Chem; 2009 Mar; 9(3):304-25. PubMed ID: 19275523 [TBL] [Abstract][Full Text] [Related]
25. Analogues of DNA minor groove cross-linking agents incorporating aminoCBI, an amino derivative of the duocarmycins: Synthesis, cytotoxicity, and potential as payloads for antibody-drug conjugates. Giddens AC; Lee HH; Lu GL; Miller CK; Guo J; Lewis Phillips GD; Pillow TH; Tercel M Bioorg Med Chem; 2016 Nov; 24(22):6075-6081. PubMed ID: 27745990 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of AminoCBIs: highly reactive but highly cytotoxic analogues of the duocarmycins. Tercel M; Pruijn FB; O'Connor PD; Liyanage HD; Atwell GJ; Alix SM Chembiochem; 2014 Sep; 15(13):1998-2006. PubMed ID: 25087870 [TBL] [Abstract][Full Text] [Related]
27. Structural, Biochemical, and Computational Studies Reveal the Mechanism of Selective Aldehyde Dehydrogenase 1A1 Inhibition by Cytotoxic Duocarmycin Analogues. Koch MF; Harteis S; Blank ID; Pestel G; Tietze LF; Ochsenfeld C; Schneider S; Sieber SA Angew Chem Int Ed Engl; 2015 Nov; 54(46):13550-4. PubMed ID: 26373694 [TBL] [Abstract][Full Text] [Related]
28. Metal cation complexation and activation of reversed CPyI analogues of CC-1065 and duocarmycin SA: partitioning the effects of binding and catalysis. Ellis DA; Wolkenberg SE; Boger DL J Am Chem Soc; 2001 Sep; 123(38):9299-306. PubMed ID: 11562212 [TBL] [Abstract][Full Text] [Related]
29. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065. Boger DL; Stauffer F; Hedrick MP Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471 [TBL] [Abstract][Full Text] [Related]
30. The effect of sulfonate leaving groups on the hypoxia-selective toxicity of nitro analogs of the duocarmycins. Ashoorzadeh A; Atwell GJ; Pruijn FB; Wilson WR; Tercel M; Denny WA; Stevenson RJ Bioorg Med Chem; 2011 Aug; 19(16):4851-60. PubMed ID: 21767954 [TBL] [Abstract][Full Text] [Related]
31. A novel, unusually efficacious duocarmycin carbamate prodrug that releases no residual byproduct. Wolfe AL; Duncan KK; Parelkar NK; Weir SJ; Vielhauer GA; Boger DL J Med Chem; 2012 Jun; 55(12):5878-86. PubMed ID: 22650244 [TBL] [Abstract][Full Text] [Related]
32. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity. Boger DL; Johnson DS; Yun W; Tarby CM Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of a series of C3-substituted CBI analogues of CC-1065 and the duocarmycins. Boger DL; Brunette SR; Garbaccio RM J Org Chem; 2001 Jul; 66(15):5163-73. PubMed ID: 11463270 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of N-aryl and N-alkenyl CBI derivatives. Parrish JP; Trzupek JD; Hughes TV; Hwang I; Boger DL Bioorg Med Chem; 2004 Nov; 12(22):5845-56. PubMed ID: 15498660 [TBL] [Abstract][Full Text] [Related]
35. Duocarmycins, potent antitumor antibiotics produced by Streptomyces sp. structures and chemistry. Yasuzawa T; Muroi K; Ichimura M; Takahashi I; Ogawa T; Takahashi K; Sano H; Saitoh Y Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):378-91. PubMed ID: 7774022 [TBL] [Abstract][Full Text] [Related]
36. A novel achiral seco-amino-cyclopropylindoline (CI) analog of CC-1065 and the duocarmycins: design, synthesis and biological studies. Toth JL; Trzupek JD; Flores LV; Kiakos K; Hartley JA; Pennington WT; Lee M Med Chem; 2005 Jan; 1(1):13-9. PubMed ID: 16789881 [TBL] [Abstract][Full Text] [Related]
37. Unexpected syntheses of seco-cyclopropyltetrahydroquinolines - from a radical 5-exo-trig cyclization reaction: analogs of CC-1065 and the duocarmycins. Pati H; Howard T; Townes H; Lingerfelt B; McNulty L; Lee M Molecules; 2004 Feb; 9(3):125-33. PubMed ID: 18007417 [TBL] [Abstract][Full Text] [Related]
38. Parallel synthesis and evaluation of 132 (+)-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogues of CC-1065 and the duocarmycins defining the contribution of the DNA-binding domain. Boger DL; Schmitt HW; Fink BE; Hedrick MP J Org Chem; 2001 Oct; 66(20):6654-61. PubMed ID: 11578217 [TBL] [Abstract][Full Text] [Related]
39. Site specific covalent alkylation of DNA by antitumor antibiotics, duocarmycin A and kapurimycin A3. Sugiyama H; Lam CK; Hosoda M; Saito I Nucleic Acids Symp Ser; 1991; (25):75-6. PubMed ID: 1842103 [TBL] [Abstract][Full Text] [Related]
40. A powerful selection assay for mixture libraries of DNA alkylating agents. Ham YW; Boger DL J Am Chem Soc; 2004 Aug; 126(30):9194-5. PubMed ID: 15281804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]